GlassScriptPhysician profile
Tyler Bernard House
NPI 1982020319
$5,384.32
in general payments reported to CMS, 2019-2025
47 companies · $948 in 2025
The $948 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $325 · 2021: $1,296 · 2022: $862 · 2023: $1,129 · 2024: $824 · 2025: $948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,901.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $749.98 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $697.18 | 2020-2025 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $438.57 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $362.59 | 2020-2025 | Airsupra, Breztri, Bevespi Aerosphere |
| Boehringer Ingelheim Pharmaceuticals, INC. | $245.15 | 2023-2025 | Ofev, Jascayd |
| Abbott Laboratories | $227.67 | 2022-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $225.88 | 2021-2025 | Vaxneuvance, Gardasil 9, Capvaxive |
| Abbvie INC. | $216.27 | 2020-2025 | |
| Exact Sciences Corporation | $191.98 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Eisai INC. | $187.99 | 2020-2025 | |
| Biohaven Pharmaceuticals, INC. | $144.80 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $116.47 | 2021-2023 | |
| Lilly USA, LLC | $115.30 | 2021-2024 | Mounjaro, Zepbound |
| Edwards Lifesciences Corporation | $96.36 | 2021 | |
| Amarin Pharma, INC. | $95.92 | 2020-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler House listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.